Our top pick for
CorVel Corporation is an insurance brokers business based in the US. CorVel Corporation shares (CRVL) are listed on the NASDAQ and all prices are listed in US Dollars. CorVel Corporation employs 3,824 staff and has a trailing 12-month revenue of around USD$554.2 million.
|52-week range||USD$44.67 - USD$110.795|
|50-day moving average||USD$103.4926|
|200-day moving average||USD$94.1675|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$2.38|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing CorVel Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CorVel Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CorVel Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 42x. In other words, CorVel Corporation shares trade at around 42x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
CorVel Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$77.9 million.
The EBITDA is a measure of a CorVel Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$554.2 million|
|Operating margin TTM||9.86%|
|Gross profit TTM||USD$125.9 million|
|Return on assets TTM||7.76%|
|Return on equity TTM||21.47%|
|Market capitalisation||USD$1.8 billion|
TTM: trailing 12 months
There are currently 208,565 CorVel Corporation shares held short by investors – that's known as CorVel Corporation's "short interest". This figure is 7.2% down from 224,629 last month.
There are a few different ways that this level of interest in shorting CorVel Corporation shares can be evaluated.
CorVel Corporation's "short interest ratio" (SIR) is the quantity of CorVel Corporation shares currently shorted divided by the average quantity of CorVel Corporation shares traded daily (recently around 37715.189873418). CorVel Corporation's SIR currently stands at 5.53. In other words for every 100,000 CorVel Corporation shares traded daily on the market, roughly 5530 shares are currently held short.
However CorVel Corporation's short interest can also be evaluated against the total number of CorVel Corporation shares, or, against the total number of tradable CorVel Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CorVel Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 CorVel Corporation shares in existence, roughly 10 shares are currently held short) or 0.0232% of the tradable shares (for every 100,000 tradable CorVel Corporation shares, roughly 23 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against CorVel Corporation.
Find out more about how you can short CorVel Corporation stock.
We're not expecting CorVel Corporation to pay a dividend over the next 12 months.
CorVel Corporation's shares were split on a 2:1 basis on 27 June 2013. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your CorVel Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for CorVel Corporation shares which in turn could have impacted CorVel Corporation's share price.
Over the last 12 months, CorVel Corporation's shares have ranged in value from as little as $44.67 up to $110.795. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while CorVel Corporation's is 0.9173. This would suggest that CorVel Corporation's shares are less volatile than average (for this exchange).
CorVel Corporation provides workers' compensation solutions for employers, third party administrators, insurance companies, and government agencies seeking to control costs and promote positive outcomes. It enables its clients to intervene and connect to the critical intelligence they need to proactively manage risk. The company offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement services, retrospective utilization review, facility claim review, professional review, pharmacy services, directed care services, Medicare solutions, clearinghouse services, independent medical examinations, and inpatient medical bill review. It also provides a range of patient management services, such as claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, life care planning, disability management, liability claims management, and auto claims management. CorVel Corporation has a partnership with PeerWell to bring remote musculoskeletal recovery to injured workers with cancelled or postponed surgery. The company was incorporated in 1987 and is based in Irvine, California.
Everything we know about the Hayward Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Alignment Healthcare Inc IPO, plus information on how to buy in.
Everything we know about the Olink Holding AB (publ) IPO, plus information on how to buy in.
Everything we know about the Procore Technologies Inc IPO, plus information on how to buy in.
Everything we know about the Navios South American Logistics Inc IPO, plus information on how to buy in.
Everything we know about the Lava Therapeutics IPO, plus information on how to buy in.
Everything we know about the Pop Culture Group Co Ltd IPO, plus information on how to buy in.
Everything we know about the Bukalapak IPO, plus information on how to buy in.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.